Key facts
| Price (PPV) | 131.40 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | valsartanhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DA03 |
| Manufacturer | SUN PHARMACEUTICALS NORTH AFRICA S.A |
| Presentation | Boite de 28 |
| Nature | Médicament |
| Hospital price | 82.10 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l’hypertension artérielle essentielle chez l’adulte. L'association Valsartan-Hydrochlorothiazide à dose fixe est indiqué chez les patients dont la pression artérielle n’est pas suffisamment contrôlée par le valsartan ou l’hydrochlorothiazide en monothérapie.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Co-Vartex 160 mg / 12.5 mg (SOTHEMA) contains the same active substance as Costarval 160 mg / 12.5 mg (Valsartan | Hydrochlorothiazide) at the same strength, but in a different pack: Boite de 14 at 74.10 MAD, i.e. 5.29 MAD per unit against 4.69 MAD for Costarval 160 mg / 12.5 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Co-Vartex 160 mg / 12.5 mg | SOTHEMA | Boite de 28 | 132.40 MAD | 4.73 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Co-Vartex 160 mg / 12.5 mg | SOTHEMA | Boite de 14 | 74.10 MAD | 5.29 / unit |
| Costarval 160 mg / 12.5 mg | SUN PHARMACEUTICALS NORTH AFRICA S.A | Boite de 14 | 74.10 MAD | 5.29 / unit |
| Co-Zenovan 160 mg / 12.5 mg | ZENITH PHARMA | Boite de 30 | 139.80 MAD | 4.66 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Costarval 160 mg / 12.5 mg
Costarval 160 mg / 12.5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by SUN PHARMACEUTICALS NORTH AFRICA S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Costarval 160 mg / 12.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Costarval 160 mg / 12.5 mg
Answers to common questions from Moroccan patients about this drug.